Status:

COMPLETED

TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection

Lead Sponsor:

Centers for Disease Control and Prevention

Collaborating Sponsors:

US Department of Veterans Affairs

Conditions:

Tuberculosis

Eligibility:

All Genders

2+ years

Phase:

NA

Brief Summary

Compared to adults, children appear to require higher weight-based doses of rifapentine to acheive comparable drug levels. TBTC Study 26, a study of the effectiveness and tolerability of weekly rifape...

Detailed Description

The pharmacokinetics of rifapentine have been studied in adults, adolescents (ages 12-15 years), and patients with hepatic dysfunction and HIV infection. However, there are no published data on the ef...

Eligibility Criteria

Inclusion

  • Enrolled in TBTC Study 26 randomized to treatment with once weekly isoniazid and rifapentine:
  • Child between the ages of 2 to less than 12 years for whom informed consent by a guardian and of assent (if applicable) have been obtained.
  • Adult greater than age 18 for whom informed consent has been obtained.
  • Willingness to undergo a blood phlebotomy 24 hours following dosing of isoniazid and rifapentine after receiving at least three once-weekly doses of rifapentine plus isoniazid.
  • If as a result of a contact investigation, both a parent and child are enrolled in Study 26, both may be co-enrolled into the pharmacokinetic substudy with the adult serving as the control for the child. Preference will be given to a biologic parent of the same gender. If no eligible biologic parent is available for study, the next adult of the same gender and at the same TBTC site, who is substudy eligible, will serve as the adult control.

Exclusion

  • None

Key Trial Info

Start Date :

September 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2008

Estimated Enrollment :

230 Patients enrolled

Trial Details

Trial ID

NCT00164450

Start Date

September 1 2005

End Date

August 1 2008

Last Update

August 25 2008

Active Locations (24)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (24 locations)

1

Central Arkansas Veterans Health System

Little Rock, Arkansas, United States, 72205

2

University of Southern California Medical Center

Los Angeles, California, United States, 90033

3

University of California at San Diego

San Diego, California, United States, 92103

4

University of California, San Francisco

San Francisco, California, United States, 94110